AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34930688 — intervention group
Group type: COMPARATOR
Intervention: General health education (control group)
Number of subjects: 2005
Study 34930688 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2005
Study 32910169 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-i6mA
Number of subjects: 3
Study 34091420 — intervention group
Group type: EXPERIMENTAL
Intervention: Encorafenib plus binimetinib
Number of subjects: 577
Study 32502179 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 0.05% eye drops (n = 19)
Number of subjects: 31
Study 32502179 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 31
Study 35523753 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic surgical repair of DF ulcers
Number of subjects: 112
Study 35523753 — intervention group
Group type: COMPARATOR
Intervention: Drug treatment
Number of subjects: 112
Study 32343909 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE; 25 min including ten 1-min intervals at 85% heart rate reserve)
Number of subjects: 9
Study 32343909 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE; 45 min at 50% heart rate reserve)
Number of subjects: 9
Study 32343909 — intervention group
Group type: COMPARATOR
Intervention: Control (30 min quiet rest)
Number of subjects: 9
Study 33059781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary changes observed at T2 (2014-2018) compared to T1 (2001-2004)
Number of subjects: 2569
Study 33059781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary GHGE from animal-based foods
Number of subjects: 2569
Study 33059781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary GHGE from discretionary foods
Number of subjects: 2569
Study 33059781 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of overweight
Number of subjects: 2569
Study 35304020 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 80
Study 32112136 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 50
Study 32112136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 36451279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash plus intervention
Number of subjects: 0
Study 36451279 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34352829 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐mL paracervical block
Number of subjects: 96
Study 34352829 — intervention group
Group type: COMPARATOR
Intervention: 20‐mL paracervical block
Number of subjects: 96
Study 36112084 — intervention group
Group type: EXPERIMENTAL
Intervention: HS-20090
Number of subjects: 154
Study 34610481 — intervention group
Group type: EXPERIMENTAL
Intervention: Somnox sleep robot intervention
Number of subjects: 44
Study 34610481 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 44
Study 32693214 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of stable dose of combination inhaled corticosteroid-long-acting beta-agonist
Number of subjects: 447
Study 32693214 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-down of inhaled corticosteroid
Number of subjects: 447
Study 32693214 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of long-acting bronchodilator
Number of subjects: 447
Study 32693214 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO levels measured serially at 6-week intervals
Number of subjects: 447
Study 35501757 — intervention group
Group type: EXPERIMENTAL
Intervention: NOOM application
Number of subjects: 320
Study 35501757 — intervention group
Group type: EXPERIMENTAL
Intervention: Walkon application
Number of subjects: 320
Study 35501757 — intervention group
Group type: EXPERIMENTAL
Intervention: Efilcare application
Number of subjects: 320
Study 35501757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 320
Study 34927230 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pyelolithotomy (LPL)
Number of subjects: 68
Study 34927230 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous nephrolithotomy (PCNL)
Number of subjects: 68
Study 34328442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia software platform for patient-reported outcomes (PRO) measures
Number of subjects: 120
Study 32144908 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal cake-partitioned moxibustion combined with Rhinocort spray (256 µg/d, once in the morning and evening, for 4 weeks)
Number of subjects: 67
Study 32144908 — intervention group
Group type: COMPARATOR
Intervention: Rhinocort spray alone (256 µg/d, once in the morning and evening, for 4 weeks)
Number of subjects: 67
Study 33780529 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month aerobic exercise intervention
Number of subjects: 96
Study 33780529 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies
Number of subjects: 96
Study 33780529 — intervention group
Group type: EXPERIMENTAL
Intervention: Referrals and Alzheimer's Association events/services
Number of subjects: 96
Study 33780529 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment cost
Number of subjects: 96
Study 33834214 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding at 1130 hours
Number of subjects: 24
Study 33834214 — intervention group
Group type: COMPARATOR
Intervention: Feeding at 0730 hours (Control)
Number of subjects: 24
Study 33834214 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding at 1530 hours
Number of subjects: 24
Study 34649266 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) diet
Number of subjects: 20
Study 34649266 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (ND)
Number of subjects: 20
Study 32593524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursolic acid (UA) 400 mg/d
Number of subjects: 22
Study 32593524 — intervention group
Group type: COMPARATOR
Intervention: Placebo 400 mg/d
Number of subjects: 22
Study 32305380 — intervention group
Group type: EXPERIMENTAL
Intervention: Equia Fil
Number of subjects: 34
Study 32305380 — intervention group
Group type: COMPARATOR
Intervention: Fuji IX GP Fast
Number of subjects: 34
Study 34919621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-speed drilling protocol without saline irrigation
Number of subjects: 23
Study 34919621 — intervention group
Group type: COMPARATOR
Intervention: Standard drilling protocol
Number of subjects: 23
Study 35258444 — intervention group
Group type: EXPERIMENTAL
Intervention: ePNa (electronic pneumonia clinical decision support)
Number of subjects: 6848
Study 36089810 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg + Losartan 50 mg
Number of subjects: 24
Study 36089810 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 24
Study 36089810 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 24
Study 32239442 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version of the survey
Number of subjects: 95
Study 32239442 — intervention group
Group type: COMPARATOR
Intervention: Text version of the survey
Number of subjects: 95
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Spelt bread (traditional recipe)
Number of subjects: 24
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Spelt bread (current recipe)
Number of subjects: 24
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bread (traditional recipe)
Number of subjects: 24
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bread (current recipe)
Number of subjects: 24
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: +FODMAP gluten-free bread
Number of subjects: 24
Study 35889757 — intervention group
Group type: EXPERIMENTAL
Intervention: +Gluten gluten-free bread
Number of subjects: 24
Study 35889757 — intervention group
Group type: COMPARATOR
Intervention: Control (wheat bread)
Number of subjects: 24
Study 34180998 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS
Number of subjects: 1603
Study 34180998 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS and elevated fasting insulin
Number of subjects: 1603
Study 34180998 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS, elevated insulin, WC >88 cm, and current smoking
Number of subjects: 1603
Study 34180998 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical depression score and PCOS diagnosis
Number of subjects: 1603
Study 34180998 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration and clinical symptoms of OSA
Number of subjects: 1603
Study 32091443 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum (Lactobacillus mixture)
Number of subjects: 166
Study 32091443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 35926544 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon pulmonary angioplasty (BPA)
Number of subjects: 61
Study 35926544 — intervention group
Group type: COMPARATOR
Intervention: Riociguat
Number of subjects: 61
Study 33866555 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline microspheres application
Number of subjects: 0
Study 33866555 — intervention group
Group type: COMPARATOR
Intervention: Control (no minocycline microspheres)
Number of subjects: 0
Study 33866555 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 33971067 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy (major autohemotherapy) applied to 37 patients, consisting of seven sessions of intravenous ozone administration (100 mL, 30 μg/mL)
Number of subjects: 55
Study 33971067 — intervention group
Group type: COMPARATOR
Intervention: Conventional COVID-19 treatment applied to 18 patients in the control group
Number of subjects: 55
Study 32045945 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemispheric stimulation
Number of subjects: 15
Study 32045945 — intervention group
Group type: COMPARATOR
Intervention: Right hemispheric stimulation
Number of subjects: 15
Study 32045945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hemispheres
Number of subjects: 15
Study 35234881 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention focused on diet and physical activity
Number of subjects: 1601
Study 35234881 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1601
Study 35169095 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab, a humanized monoclonal antibody targeting vascular endothelial growth factor.
Number of subjects: 0
Study 35169095 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified.
Number of subjects: 0
Study 33188747 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide (1.0 g/day) for 14 days
Number of subjects: 100
Study 33188747 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine (1.5-2 g/day) for 14 days
Number of subjects: 100
Study 33188747 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nitazoxanide (1.0 g/day) and mesalazine (≥1.5-2 g/day) for 14 days
Number of subjects: 100
Study 33188747 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 100
Study 32439340 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (140mg; n=17)
Number of subjects: 36
Study 32439340 — intervention group
Group type: COMPARATOR
Intervention: Non-evolocumab (n=19)
Number of subjects: 36
Study 33866933 — intervention group
Group type: COMPARATOR
Intervention: Daily intake of 100 mg oral ferrous fumarate
Number of subjects: 217
Study 33866933 — intervention group
Group type: EXPERIMENTAL
Intervention: Every other day intake of 100 mg oral ferrous fumarate
Number of subjects: 217
Study 34184596 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive strategy training
Number of subjects: 53
Study 34184596 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 53
Study 33006615 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma Therapy
Number of subjects: 0
Study 33006615 — intervention group
Group type: COMPARATOR
Intervention: Standard Therapy Placebo
Number of subjects: 0
Study 34260716 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine
Number of subjects: 0
Study 34260716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32052517 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 675
Study 32052517 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel plus aspirin
Number of subjects: 675
Study 35258042 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) twice per day for 7 days before surgery
Number of subjects: 120
Study 35258042 — intervention group
Group type: COMPARATOR
Intervention: No ONS
Number of subjects: 120
Study 33955943 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with intrascleral collagen implant (DSCI)
Number of subjects: 13
Study 33955943 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with suprachoroidal collagen implant (DSSCI)
Number of subjects: 13
Study 35028669 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface-treated miniscrews
Number of subjects: 39
Study 35028669 — intervention group
Group type: COMPARATOR
Intervention: Non-treated miniscrews
Number of subjects: 39
Study 34707516 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for Awareness, Resilience and Action (TARA)
Number of subjects: 0
Study 34707516 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (including but not limited to antidepressant medication and/or psychotherapy)
Number of subjects: 0
Study 32030497 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with aspiration thrombectomy
Number of subjects: 432
Study 32030497 — intervention group
Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 432
Study 32789453 — intervention group
Group type: EXPERIMENTAL
Intervention: WZB117 with NaF plus EDTA-Na2 (C group)
Number of subjects: 80
Study 32789453 — intervention group
Group type: COMPARATOR
Intervention: NaF plus EDTA-Na2 without WZB117 (A group)
Number of subjects: 80
Study 32789453 — intervention group
Group type: COMPARATOR
Intervention: Citric acid, trisodium citrate, and EDTA-Na2 without WZB117 (B group)
Number of subjects: 80
Study 32789453 — intervention group
Group type: COMPARATOR
Intervention: A group (NaF plus EDTA-Na2)
Number of subjects: 80
Study 32789453 — intervention group
Group type: EXPERIMENTAL
Intervention: C group (WZB117 with NaF plus EDTA-Na2)
Number of subjects: 80
Study 33010094 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic remedies
Number of subjects: 150
Study 33010094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33010094 — intervention group
Group type: COMPARATOR
Intervention: Control (no homeopathic treatment)
Number of subjects: 150
Study 35577034 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX) 10, 20, 30 mg pooled
Number of subjects: 199
Study 35577034 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX) pooled
Number of subjects: 199
Study 34085763 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing for patients (Arm 1)
Number of subjects: 510
Study 34085763 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing for patients and caregivers (Arm 2)
Number of subjects: 510
Study 34085763 — intervention group
Group type: COMPARATOR
Intervention: Control group (Arm 3)
Number of subjects: 510
Study 32891803 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 783
Study 34193059 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge 24 hours after cesarean (Group A)
Number of subjects: 294
Study 34193059 — intervention group
Group type: COMPARATOR
Intervention: Discharge 48 hours after cesarean (Group B)
Number of subjects: 294
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum (200 mg/L)
Number of subjects: 1138
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional milk (171 mg/L)
Number of subjects: 1138
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Mature milk (126 mg/L)
Number of subjects: 1138
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma total cholesterol (TC)
Number of subjects: 1138
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 1138
Study 33846555 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnic comparison (Tibetan vs. Hui)
Number of subjects: 1138
Study 33507626 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nurse-led tele-homecare program
Number of subjects: 200
Study 33507626 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard home care)
Number of subjects: 200
Study 35780788 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 (AZD1222) vaccine
Number of subjects: 0
Study 35780788 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32014696 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackbox
Number of subjects: 47
Study 32014696 — intervention group
Group type: COMPARATOR
Intervention: LapMentor
Number of subjects: 47
Study 35710043 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie optimal defaults
Number of subjects: 377
Study 35710043 — intervention group
Group type: COMPARATOR
Intervention: Traditional high-calorie default items
Number of subjects: 377
Study 35710043 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal defaults
Number of subjects: 377
Study 35710043 — intervention group
Group type: COMPARATOR
Intervention: Traditional combos
Number of subjects: 377
Study 33992249 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training (2 to 4 weekly sessions for 10 weeks)
Number of subjects: 35
Study 33992249 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study 32964939 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer with intensified luteal phase support (1500 IU hCG, oral estradiol 2 mg twice daily, micronized vaginal progesterone 200 mg three times daily)
Number of subjects: 212
Study 32964939 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-all strategy followed by frozen embryo transfer
Number of subjects: 212
Study 33894518 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lead levels (BLLs) of household children (preschool-aged and school-aged)
Number of subjects: 404
Study 33894518 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lead levels (BLLs) of mothers
Number of subjects: 404
Study 35653590 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic heparin
Number of subjects: 0
Study 35653590 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic-dose heparin
Number of subjects: 0
Study 33268429 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the study diagnostic aid for hip checks
Number of subjects: 16640
Study 33268429 — intervention group
Group type: COMPARATOR
Intervention: Standard care for hip checks
Number of subjects: 16640
Study 35001815 — intervention group
Group type: EXPERIMENTAL
Intervention: PR + IMT
Number of subjects: 51
Study 35001815 — intervention group
Group type: COMPARATOR
Intervention: PR alone
Number of subjects: 51
Study 32604783 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating microRNAs in serum of ILA subjects
Number of subjects: 81
Study 32604783 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects without ILA)
Number of subjects: 81
Study 33783227 — intervention group
Group type: EXPERIMENTAL
Intervention: BM-MSC (20 × 10^6 cells)
Number of subjects: 20
Study 33783227 — intervention group
Group type: EXPERIMENTAL
Intervention: Lp-PRP
Number of subjects: 20
Study 33783227 — intervention group
Group type: COMPARATOR
Intervention: BM-MSC
Number of subjects: 20
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 10 mg Zn/kg feed
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 20 mg Zn/kg feed
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 40 mg Zn/kg feed
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 80 mg Zn/kg feed
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 160 mg Zn/kg feed
Number of subjects: 504
Study 32416830 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (27.7 mg/kg Zn)
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Zn supplementation
Number of subjects: 504
Study 32416830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Zn requirements
Number of subjects: 504
Study 34407032 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced mindfulness-based stress reduction (MBSR+)
Number of subjects: 98
Study 34407032 — intervention group
Group type: COMPARATOR
Intervention: Stress management for headache (control)
Number of subjects: 98
Study 35036447 — intervention group
Group type: COMPARATOR
Intervention: Conventional lifestyle intervention plus placebo
Number of subjects: 1945
Study 35036447 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention plus placebo
Number of subjects: 1945
Study 35036447 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional lifestyle intervention plus pioglitazone
Number of subjects: 1945
Study 35036447 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention plus pioglitazone
Number of subjects: 1945
Study 33246650 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based CBT (iCBT)
Number of subjects: 304
Study 33246650 — intervention group
Group type: COMPARATOR
Intervention: telephone-delivered CBT (tCBT)
Number of subjects: 304
Study 33246650 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (iCBT and tCBT)
Number of subjects: 304
Study 35848821 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dextrose prolotherapy (5cc under ultrasound guidance)
Number of subjects: 54
Study 35848821 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (1 ml triamcinolone 40 mg/ml under ultrasound guidance)
Number of subjects: 54